Vertex Pharmaceuticals, Inc. (VRTX)
443.53
-3.30
(-0.74%)
USD |
NASDAQ |
Jun 08, 14:28
Vertex Pharmaceuticals Total Assets (Quarterly) : 26.48B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.87B |
| Biogen, Inc. | 29.48B |
| CRISPR Therapeutics AG | 2.726B |
| Halozyme Therapeutics, Inc. | 2.673B |
| Gilead Sciences, Inc. | 56.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.122B |
| Shareholders Equity (Quarterly) | 19.36B |
| Debt to Equity Ratio | 0.1026 |
| Current Ratio | 3.023 |
| Net Debt Paydown Yield | -0.04% |